Cas 676494-22-7,Carbamic acid, [2-[4-(3-chloro-4-cyanophenoxy)phenyl]ethyl](phenylmethyl)-, 1,1-dimethylethyl ester

676494-22-7

Post Buying Request

Basic information

Product Name: Carbamic acid, [2-[4-(3-chloro-4-cyanophenoxy)phenyl]ethyl](phenylmethyl)-, 1,1-dimethylethyl ester
Synonyms:
CAS NO:676494-22-7
Molecular Formula: C27H27ClN2O3
Molecular Weight: 462.976
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Carbamic acid, [2-[4-(3-chloro-4-cyanophenoxy)phenyl]ethyl](phenylmethyl)-, 1,1-dimethylethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: Carbamic acid, [2-[4-(3-chloro-4-cyanophenoxy)phenyl]ethyl](phenylmethyl)-, 1,1-dimethylethyl ester(676494-22-7)
EPA Substance Registry System: Carbamic acid, [2-[4-(3-chloro-4-cyanophenoxy)phenyl]ethyl](phenylmethyl)-, 1,1-dimethylethyl ester(676494-22-7)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 676494-22-7(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

676494-22-7 Suppliers

Recommended suppliers

676494-22-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 676494-22-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,4,9 and 4 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 676494-22:
(8*6)+(7*7)+(6*6)+(5*4)+(4*9)+(3*4)+(2*2)+(1*2)=207
207 % 10 = 7
So 676494-22-7 is a valid CAS Registry Number.

676494-22-7Upstream product

676494-22-7Downstream Products

676494-22-7Relevant academic research and scientific papers

DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONIST

-

Page/Page column 128, (2008/06/13)

A compound of the formula (I) wherein the variables X1 to X10, R1 to R7 including R3', E, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 676494-22-7